BAC
Bank of America Corporation
BAC has the edge over SCM overall, supported by stronger fundamentals and stronger valuation.
SCM
Stellus Capital Investment Corporation
SCM trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SCM Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| N/A | |
| N/A |
SCM's profitability is currently healthy, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like SCM.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over SCM in the historical PE scenario, which offers more potential upside but is not a forecast.
SCM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.3x | $6.67 | — |
| Cheap | 7x | $4.07 | -39% |
| Fair | 10x | $5.85 | -12% |
| Current | 12x | $6.67 | — |
| Expensive | 20x | $11.34 | +70% |
Historical ranges are pointers, not guarantees.
SCM's PE is in its fair range at 12x. On analysts' estimates for next year's earnings, today's price would be 6.3x, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over SCM on the outlook, with more favorable earnings and revenue expectations.
SCM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect SCM's profitability to improve, but its revenue to decline.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over SCM on earnings, with more consistent year-over-year improvement.
SCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.05 | +82% |
| Q3 2026 | $0.58 | -46% |
| Q2 2026 | $1.03 | -28% |
| Q1 2026 | $0.83 | -42% |
| Q4 2025 | $0.95 | -47% |
| Q3 2025 | $1.08 | -45% |
| Q2 2025 | $1.44 | +13% |
| Q1 2025 | $1.43 | +30% |
| Q4 2024 | $1.79 | +124% |
SCM's earnings per share have fallen from their peak: $0.58 over the past year, against $3.54 in early 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 25% for SCM.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
SCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $8.7M | -25% |
| Q1 2022 | $11.8M | +2.2% |
| Q4 2021 | $17.9M | -17% |
| Q3 2021 | $20.4M | +56% |
| Q2 2021 | $11.6M | -74% |
| Q4 2020 | $21.6M | +199% |
SCM's revenue fell from its 2020 peak and has held roughly level since: $9M last quarter, down 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 22% | -27 points |
| Q1 2022 | 47% | +0.5 points |
| Q4 2021 | 66% | -12 points |
| Q3 2021 | 70% | +8.9 points |
| Q2 2021 | 49% | -40 points |
| Q1 2021 | 46% | N/A |
| Q4 2020 | 78% | +50 points |
| Q3 2020 | 61% | N/A |
SCM's operating margin was 22% last quarter, down 27 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
SCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $957.1K | +$21.2M |
| Q2 2026 | $33.4M | +41% |
| Q1 2026 | $22.8M | +$59.7M |
| Q4 2025 | $9M | +$40.8M |
| Q3 2025 | -$20.2M | -272% |
| Q2 2025 | $23.7M | +$36.8M |
| Q1 2025 | -$36.9M | -928% |
| Q4 2024 | -$31.8M | -226% |
SCM has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SCM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -403K shares |
| 1 year | -0.1% | -14.8K shares |
| 3 years | +25% | +5.6M shares |
| 5 years | +46% | +9M shares |
| Available history | +47% | +9M shares |
SCM has 28M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.1M |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $2.00 |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 16.8x | High |
| Q1 2022 | 14.5x | High |
| Q4 2021 | 12.8x | High |
| Q3 2021 | 11.7x | High |
| Q2 2021 | 13.9x | High |
| Q1 2021 | 6.2x | High |
| Q4 2020 | 17.7x | High |
| Q3 2020 | 54.9x | High |
SCM's net debt is about 17 years of its operating earnings (EBITDA), up from 14 years a year ago. Net leverage isn't a meaningful measure for financial services companies like SCM.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.6 | Neutral |
| Stochastic | 18.1 | Oversold |
SCM's weekly RSI is 34 (neutral) and its Stochastic is 18 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
SCM PE vs Financial Services Sector
| Metric | SCM | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 12% below |
| PE % | 60 | 63 | 3 pts below |
SCM has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over SCM on trend strength, trading above more of its moving averages.
SCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.11 | 6.2% below |
| 20 week MA | $7.76 | 14% below |
| 50 week MA | $9.41 | 29% below |
| 100 week MA | $11.5 | 42% below |
| 200 week MA | $12.7 | 47% below |
SCM is in a downtrend: it's below all five of its weekly moving averages, and 47% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over SCM on returns for 2026, with the stronger performance.
SCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.5 | $10.7 | -26% |
| 2021 | $10.7 | $13.0 | +21% |
| 2022 | $13.0 | $13.0 | +0.5% |
| 2023 | $13.0 | $12.9 | -1.4% |
| 2024 | $12.9 | $13.8 | +7% |
| 2025 | $13.8 | $12.6 | -8.6% |
| 2026 YTD | $12.6 | $6.67 | -47% |
SCM has finished lower in three of the last six years. It's down 47% so far in 2026.